MetLife Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

MetLife Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,141	Closed	-$128K	–	2359
2019 Q3	$128K	Hold	26,141	–	–	﹤0.01%	2197
2019 Q2	$159K	Hold	26,141	–	–	﹤0.01%	2162
2019 Q1	$152K	Hold	26,141	–	–	﹤0.01%	2129
2018 Q4	$352K	Hold	26,141	–	–	﹤0.01%	1583
2018 Q3	$507K	Hold	26,141	–	–	0.01%	1535
2018 Q2	$668K	Buy	26,141 +3,833	+17%	+$89.4K	0.01%	1228
2018 Q1	$450K	Hold	22,308	–	–	0.01%	1431
2017 Q4	$448K	Buy	+22,308	New	+$439K	0.01%	1462

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MetLife Investment Management's DPLO Position: Q4 2019 in Review

MetLife Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 26,141 shares — an estimated $128K sold.

MetLife Investment Management first reported a position in DPLO in Q4 2017 and held it in 8 quarters. The position peaked at $668K in Q2 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

MetLife Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
MetLife Investment Management sold 26,141 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $128K.
MetLife Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 8 quarters.
MetLife Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $668K in Q2 2018.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.